Am I Depressed?

The International Study to Predict Optimised Treatment Response – in Depression (iSPOT-D)

United States, New Zealand and Australia.

Brain Dynamics Centre Australia Swinburne University of Technology Australia The Alfred Hospital Australia University of Auckland New Zealand ADD Treatment Center United States Center for Healing the Human Spirit United States Stanford University United States Brain Dynamics Centre Westmead Hospital Sydney NSW, Australia   Swinburne University of Technology Brain Sciences Institute Melbourne VIC, Australia   The Alfred Hospital Monash Alfred University Psychiatry Research Centre Melbourne VIC, Australia   University of Auckland Pharmacy Auckland, New Zealand   ADD Treatment Center iSpot-D Clinical Laboratory Mission Viejo California, United States   Center for Healing the Human Spirit iSPOT-D Clinical Laboratory Tarzana California, United States   Stanford University Department of Psychiatry Stanford California, United States

ADD Treatment Center Department iSpot-D Clinical Laboratory Coordinator Jeffrey Wilson Postal Address 27725 Santa Margarita Pkwy #215 Mission Viejo, CA 92691 United States Phone 949 272 3870 Fax 949 951 2802 Contact by Email

Our Research:

We know that less than 40% of people with depression respond to their first treatment with an antidepressant. There is also no way for clinicians to determine whether one antidepressant will be more beneficial than another. iSPOT-D is the largest international research study ever undertaken into Major Depressive Disorder that aims to develop a simple assessment tool to help health care professionals to prescribe each individual onto the right medication first go. Our site is one of 18 sites world-wide.

What is involved:

• Two assessment visits:
  • Before taking the antidepressant medication &
  • 8 weeks after starting the medication
• Follow-up calls 

Your Clinician will be sent reports and asked to prescribe and titrate the medication. As this is a research project you will be randomized to one of three commonly prescribed medications (escitalopram SSRI, venlafaxine XR SNRI, and sertraline SSRI) on your first visit.

This research study is free of charge and participants are reimbursed for travel expenses and time.

Report Provided:

• Symptom reports
• Diagnostic & severity interviews (before & after medication)
• Thought & information processing reports (before & after medication)
• Brain Scans (MRI report). (This component is only available at some sites) 

Can I take part in iSPOT-D research?

To be included in this research, you MUST meet the following criteria:

If you answer YES for all of the above criteria, you are invited to take part in our research.

I would like to submit my details to be involved as a depressed participant.

Please DO NOT enter personal information on behalf of another individual.

*Personal information collected will only be disclosed to the research team in order to contact you. Personal information will not be disclosed outside of the resaerch site(s).